Pharmaceutical

Johnson & Johnson 2025 Q2 Earnings Report Financial statements Johnson & Johnson Johnson & Johnson's Q2 2025 earnings report highlights strong growth across Innovative Medicine and MedTech, driven by oncology breakthroughs and cardiovascular innovation despite industry headwinds.
Hansoh and Hengrui: A Pharmaceutical Power Couple Hengrui Hansoh Pharma Discover how Hansoh Pharmaceutical transformed from a generic drugmaker into a global innovator through aggressive R&D, strategic partnerships, and successful international launches like Almonertinib.
Johnson & Johnson 2025 H1 Performance Financial statements Johnson & Johnson Johnson & Johnson reports $45.64B revenue in H1 2025, driven by oncology growth. Darzalex hits $6.8B, Carvykti surges toward $2B. Neuroscience and immunology portfolios evolve amid strategic acquisitions.
Novartis Q2 2025 Earnings Report Financial statements Novartis Novartis reported strong Q2 2025 results with double-digit revenue growth, key product successes, and promising R&D breakthroughs. The company's innovation and strategic focus position it for sustained long-term leadership.
Global Biopharma Layoffs July 2025 Layoffs Layoff GSK BMS Merck Biopharmaceutical industry sees major July layoffs, with companies like Sarepta, GSK, Century, and Sage Therapeutics cutting jobs amid restructurings, trial setbacks, and M&A activity.
FDA Reconsiders Elevidys Amid Safety Concerns FDA Sarepta The FDA is reevaluating Sarepta's gene therapy Elevidys after a third patient death linked to its treatments. The agency may halt shipments amid rising safety concerns and market fallout.
WuXi AppTec Q2 2025 Earnings Report Financial statements Market Trend WuXi AppTec CDMO U.S. CDMOs face strategic setbacks amid global supply chain shifts, while China, South Korea, and Europe intensify competition in high-growth biotech sectors like CGT and ADC, reshaping the global CDMO landscape.
Trump's Big Beautiful Bill: Impact on US Pharma & Global Healthcare Lessons Pharmaceutical Deep analysis of Trump's healthcare reform bill - how Medicaid cuts, orphan drug exemptions & tax breaks reshape US pharma, with crucial lessons for China's healthcare policy makers.
Chugai Taps Gero's AI in $1B+ Aging R&D Deal Roche Gero Chugai Pharmaceutical Anti-Aging Chugai Pharmaceutical teams up with AI biotech Gero in a $1B+ deal to develop antibody therapies targeting aging-related diseases. The partnership leverages Gero’s AI platform and supports Chugai’s global innovation strategy.
Amarin Partners with Recordati to Reinvigorate European Vascepa Sales Amarin Recordati Amarin licenses European rights to heart drug Vazkepa to Recordati for $25M upfront, aiming to revive sales amid U.S. decline. The deal includes milestones, royalties, and supports Amarin’s strategic restructuring and cost-saving goals.

< Pre 1...41 42 434445 46 47...87 Next >

Articles Archives

Hot Articles

Related Exhibition

All Categories

Agri & Industry Cosmetic Food History Laboratory

HOT Topics

Hot Articles